Top compounds associated with response to YIF1A


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.15 1e-06
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.17 2e-06
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.15 2e-06
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 2e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA CX-5461 GDSC1000 pan-cancer AAC -0.16 4e-06
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 5e-06
mRNA MK 1775 CTRPv2 pan-cancer AAC -0.16 5e-06
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.16 6e-06
mRNA etoposide CTRPv2 pan-cancer AAC -0.14 8e-06
Download CSV